Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026 Research and Development AI, NVIDIA, Roche

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance graphics processing units (GPUs) across …
News

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026 Research and Development EndoCyclic Therapeutics, FDA, endometriosis

EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …
News

Outrun Therapeutics announces its lead programme for HPV positive cancer

March 23, 2026 Research and Development HPV, Oncology, Outrun Therapeutics

Outrun Therapeutics has selected an E6AP inhibitor strategy as its lead programme for treating HPV positive head and neck cancer. …
News

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026 Research and Development NHS, University of Huddersfield, West Yorkshire

Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, has visited the recently opened Emily Siddon …
News

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026 Research and Development DiaMedica, Health Canada, preeclampsia

DiaMedica Therapeutics has received a No Objection Letter (NOL) from Health Canada, giving the company regulatory clearance to start its …
News

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026 Research and Development Abselion, The Engine, US

Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. The company aims to strengthen …
News

Antiverse receive investment from IIC and Development Bank of Wales

March 9, 2026 Research and Development Antiverse, Wales, funding

As part of its $9.3m Series A funding round, Antiverse has received a joint equity investment by Innovation Investment Capital …
News

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026 Research and Development Curie.Bio, Secarna Pharmaceuticals, partnership

Secarna Pharmaceuticals has announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio. The collaboration, first announced …
News

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026 Research and Development Siemens Healthineers

Siemens Healthineers has opened a new Centre of Excellence for Immunoassay Instrument Research & Development in Swords, Ireland. Over 10m …
News

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026 Research and Development Eylea HD, Opthalmology, Regeneron

Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data was presented as part of …
News

New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone

February 16, 2026 Research and Development Cardiology, Carvolix

Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …
News

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026 Research and Development Cardiology, Rhythm AI, atrial fibrillation

Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …
News

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026 Research and Development Infinitopes, Oncology

Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …
News

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026 Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …
News

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026 Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026